Openvas by Daiichi Sankyo launched in Mexico

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: Japan-based Daiichi Sankyo has launched antihypertensive franchise olmesartan medoxomil in Mexico under the n...Read more

Osteoporosis is an emerging crisis in APAC: Report

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 2 Comment | 13 Dec, 2013

Singapore: A new report, launched by the International Osteoporosis Foundation (IOF), shows that osteoporosis is a loomi...Read more

Genting to acquire 20% equity stake in TauRx

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2012

Singapore: Singapore-based TauRx Pharmaceuticals has received equity investment of $31.5 million from Genting Management...Read more

Nanotherapeutics seeks GE help to step up development

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2014

Singapore: Biopharmaceutical company Nanotherapeutics has selected GE Healthcare Life Sciences' FlexFactory biomanufactu...Read more

Steroid pioneer gets Heritage Foundation, BIO award

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 3 Comment | 22 Apr, 2013

Singapore: Chemical Heritage Foundation (CHF) and Biotechnology Industry Organization (BIO) have selected Mexican steroi...Read more

Austrianova starts cell bank for cancer therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials...Read more

Takeda, Dainippon to market schizophrenia drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

Singapore: Japanese companies Dainippon Sumitomo Pharma and Takeda Pharmaceutical have obtained approval for marketing a...Read more

Astellas to pay $300 mn for cancer drug conjugates

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2013

Singapore: Japan's Astellas Pharma has collaborated with US-based Ambrx for the discovery and development of novel antib...Read more

Jubilant, Janssen expand drug discovery alliance

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Feb, 2014

Singapore: Jubilant Biosys, a subsidiary of Bangalore-based Jubilant Life Sciences, has expanded its drug discovery alli...Read more

Patrys' 2nd group concludes treatment in Germany

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Apr, 2013

Singapore: Patrys completed initial treatment of second group of three patients in its phase I/IIa PAT-SM6 multiple myel...Read more

AstraZeneca biologics R&D arm acquires Amplimmune

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2013

Singapore: AstraZeneca's global biologics R&D arm, MedImmune, plans to acquire Amplimmune, which is a US-based biolo...Read more

Biostar, Shaanxi Uni to co-develop liver cancer drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2014

Singapore: Biostar Pharmaceuticals, a China-based manufacturer and marketer of pharmaceutical and health supplement prod...Read more

Otsuka schizophrenia relapse gets FDA nod

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 01 Mar, 2013

Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripipra...Read more

Novogen to develop new class of cancer drugs

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2013

Singapore: Australia-based Novogen has acquired a novel drug technology that will be developed as a potentially major cl...Read more

FDA issues complete response letter for XARELTO

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 22 Jun, 2012

Singapore: US Food and Drug Administration (FDA) have issued a complete response letter regarding a supplemental New Dru...Read more

Sanofi to develop novel drugs for drug-resistant TB

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2012

Singapore: Sanofi and the Global Alliance for TB Drug Development (TB Alliance) entered a research collaboration to acce...Read more

Lupin aims high with a strong R&D focus

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2012

Lupin Pharmaceutical, which aims to be the best transnational pharmaceutical company in the world, stroked 10.64 percent...Read more

Phosphagenics appoints three new non-executive directors

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 3 Comment | 04 Mar, 2014

Singapore: Australian drug delivery technology company Phosphagenics has appointed biotech industry veterans Mr Lawrence...Read more